My investments, (not bets), as regards biotechs, are mainly based on the science, NOT the person.
I've spent years investing in biotechs, many with good results and many failures. RARELY, if ever, were my decisions based on the person. Take IMMU, for example. And yes, based on the approvals IBRX has received, I do feel that we are very safe with the current price point of the shares. Very little downside and very great upside, at this point. I do have other investments that are based very much on the person, but rarely if ever in biotechs. Good luck to you with your deep understandings of PSS and those like him.
Thanks for your comments, and, of course mine are just that.... IMO. |
